Nomura Securities analyst M. Ian Somaiya named BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) his top mid-cap Biotech pick for 2015 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE